Clare L Scott (Clare Scott)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Endometrial Cancer

Dna Damage Response

Top Venues

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature genetics

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Kortnye Smith, Sophie O'Haire, Benjamin Markman, Hui Kong Gan, Kenneth J O'Byrne, Michael Millward, Ben Tran, Benjamin J Solomon, Clare L Scott, Damien Kee, Grant A McArthur, Andrew P Fellowes, Dong Anh K Khoung-Quang, Paul G Ekert, Paul A James, Huiling Xu, Melissa Martyn, Elly Lynch, Rona Weerasuriya, Clara L Gaff, Stephen B Fox, Jayesh Desai
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery. JCO precision oncology 8 (2024)
Robyn A Smith, Judith Slocombe, Jo Cockwill, Kathy Minas, George Kiossoglou, Katya Gray, William Lawrence, Michelle Iddles, Clare L Scott, Lorraine Ann O'Reilly
Patient and public involvement in preclinical and medical research: Evaluation of an established programme in a Discovery-Based Medical Research Institute. Health expectations : an international journal of public participation in health care and health policy 27 (1) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robyn A Smith, Judith Slocombe, Jo Cockwill, Kathy Minas, George Kiossoglou, Katya Gray, William Lawrence, Michelle Iddles, Clare L Scott, Lorraine Ann O'Reilly
Patient and public involvement in preclinical and medical research: Evaluation of an established programme in a Discovery-Based Medical Research Institute. Health expectations : an international journal of public participation in health care and health policy 27 (1) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Nikki L Burdett, Madelynne O Willis, Kathryn Alsop, Allison L Hunt, Ahwan Pandey, Phineas T Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sian Fereday, Joy Hendley, Dale W Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L Hood, Katlin N Wilson, Kelly A Conrads, Kathleen I Pishas, Sumitra Ananda, Clare L Scott, Yoland Antill, Orla McNally, Linda R Mileshkin, Anne Hamilton, George Au-Yeung, Lisa Devereux, Heather Thorne, Andrea H Bild, Nicholas W Bateman, G Larry Maxwell, Jeffrey T Chang, Thomas P Conrads, Brad H Nelson, David D L Bowtell, Elizabeth L Christie
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature genetics 55 (3) (2023)
Zoe R C Marks, Nicole K Campbell, Niamh E Mangan, Cassandra J Vandenberg, Linden J Gearing, Antony Y Matthews, Jodee A Gould, Michelle D Tate, Georgie Wray-McCann, Le Ying, Sarah Rosli, Natasha Brockwell, Belinda S Parker, San S Lim, Maree Bilandzic, Elizabeth L Christie, Andrew N Stephens, Eveline de Geus, Matthew J Wakefield, Gwo-Yaw Ho, Orla McNally, null null, Iain A McNeish, David D L Bowtell, Nicole A de Weerd, Clare L Scott, Nollaig M Bourke, Paul J Hertzog
Interferon-ε is a tumour suppressor and restricts ovarian cancer. Nature (2023)
Nikki L Burdett, Madelynne O Willis, Kathryn Alsop, Allison L Hunt, Ahwan Pandey, Phineas T Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sian Fereday, Joy Hendley, Dale W Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L Hood, Katlin N Wilson, Kelly A Conrads, Kathleen I Pishas, Sumitra Ananda, Clare L Scott, Yoland Antill, Orla McNally, Linda R Mileshkin, Anne Hamilton, George Au-Yeung, Lisa Devereux, Heather Thorne, Andrea H Bild, Nicholas W Bateman, G Larry Maxwell, Jeffrey T Chang, Thomas P Conrads, Brad H Nelson, David D L Bowtell, Elizabeth L Christie
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature genetics 55 (3) (2023)
Nikki L Burdett, Madelynne O Willis, Kathryn Alsop, Allison L Hunt, Ahwan Pandey, Phineas T Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sian Fereday, Joy Hendley, Dale W Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L Hood, Katlin N Wilson, Kelly A Conrads, Kathleen I Pishas, Sumitra Ananda, Clare L Scott, Yoland Antill, Orla McNally, Linda R Mileshkin, Anne Hamilton, George Au-Yeung, Lisa Devereux, Heather Thorne, Andrea H Bild, Nicholas W Bateman, G Larry Maxwell, Jeffrey T Chang, Thomas P Conrads, Brad H Nelson, David D L Bowtell, Elizabeth L Christie
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature genetics (2023)
Nicola S Meagher, Kylie L Gorringe, Matthew J Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S Chiu, Michael S Anglesio, Kylie-Ann Mallitt, Jennifer Anne Doherty, Holly R Harris, Joellen M Schildkraut, Andrew Berchuck, Kara L Cushing-Haugen, Ksenia Chezar, Angela Chou, Adeline Tan, Jennifer Alsop, Ellen L Barlow, Matthias W Beckmann, Jessica Boros, David D L Bowtell, Alison H Brand, James D Brenton, Ian G Campbell, Dane Cheasley, Joshua G Cohen, Cezary Cybulski, Esther Elishaev, Ramona Erber, Rhonda Farrell, Anna Katharina Fischer, Zhuxuan Fu, C Blake Gilks, Anthony J Gill, Charlie Gourley, Marcel Grube, Paul R Harnett, Arndt Hartmann, Anusha Hettiaratchi, Claus K Høgdall, Tomasz Huzarski, Anna Jakubowska, Mercedes Jimenez-Linan, Catherine J Kennedy, Byoung Gie Kim, Jae-Weon Kim, Jae-Hoon Kim, Kayla Klett, Jennifer M Koziak, Tiffany Lai, Angela Laslavic, Jenny Lester, Yee Leung, Na Li, Winston Liauw, Belle W X Lim, Anna Linder, Jan A Lubiński, Sakshi Mahale, Constantina Mateoiu, Simone McInerny, Janusz Menkiszak, Parham Minoo, Suzana Mittelstadt, David L Morris, Sandra Orsulic, Sang-Yoon Park, Celeste Leigh Pearce, John V Pearson, Malcolm C Pike, Carmel M Quinn, Ganendra Raj Mohan, Jian Yu Rao, Marjorie J Riggan, Matthias Ruebner, Stuart Salfinger, Clare L Scott, Mitul Shah, Helen Steed, Colin J R Stewart, Deepak N Subramanian, Soseul Sung, Katrina Tang, Paul Timpson, Robyn L Ward, Rebekka Wiedenhoefer, Heather Thorne, Paul Andrew Cohen, Philip J Crowe, Peter Andreas Fasching, Jacek Gronwald, Nicholas J Hawkins, Estrid V S Høgdall, David G Huntsman, Paul A James, Beth Y Karlan, Linda E Kelemen, Stefan Kommoss, Gottfried E Konecny, Francesmary Modugno, Sue-Kyung Park, Annette Staebler, Karin Sundfelt, Anna H Wu, Aline Talhouk, Paul David Peter Pharoah, Lyndal Anderson, Anna De Fazio, Martin Koebel, Michael L Friedlander, Susan J Ramus
Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Gwo-Yaw Ho, Elizabeth L Kyran, Justin Bedő, Matthew J Wakefield, Darren P Ennis, Hasan B Mirza, Cassandra J Vandenberg, Elizabeth Lieschke, Andrew Farrell, Anthony Hadla, Ratana Lim, Genevieve Dall, James E Vince, Ngee Kiat Chua, Olga Kondrashova, Rosanna Upstill-Goddard, Ulla-Maja Bailey, Suzanne Dowson, Patricia Roxburgh, Rosalind M Glasspool, Gareth Bryson, Andrew V Biankin, null null, Susanna L Cooke, Gayanie Ratnayake, Orla McNally, Nadia Traficante, null null, Anna De Fazio, John S Weroha, David D L Bowtell, Iain A McNeish, Anthony T Papenfuss, Clare L Scott, Holly E Barker
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin. Cancer research 82 (23) (2022)
Zhen Xu, Cassandra J Vandenberg, Elizabeth Lieschke, Ladina Di Rago, Clare L Scott, Ian J Majewski
CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP Inhibitors. Molecular cancer research : MCR 19 (8) (2021)
Elizabeth M Swisher, Tanya T Kwan, Amit M Oza, Anna V Tinker, Isabelle L Ray-Coquard, Ana Oaknin, Robert L Coleman, Carol Aghajanian, Gottfried E Konecny, David M O'Malley, Alexandra Leary, Diane Provencher, Stephen Welch, Lee-May Chen, Andrea E Wahner Hendrickson, Ling Ma, Prafull Ghatage, Rebecca S Kristeleit, Oliver Dorigo, Ashan Musafer, Scott H Kaufmann, Julia A Elvin, Douglas I Lin, Setsuko K Chambers, Erin Dominy, Lan-Thanh Vo, Sandra Goble, Lara Maloney, Heidi Giordano, Thomas Harding, Alexander Dobrovic, Clare L Scott, Kevin K Lin, Iain A McNeish
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2). Nature communications 12 (1) (2021)
Ksenija Nesic, Olga Kondrashova, Rachel M Hurley, Cordelia D McGehee, Cassandra J Vandenberg, Gwo-Yaw Ho, Elizabeth Lieschke, Genevieve Dall, Nirashaa Bound, Kristy Shield-Artin, Marc Radke, Ashan Musafer, Zi Qing Chai, Mohammad Reza Eftekhariyan Ghamsari, Maria I Harrell, Damien Kee, Inger Olesen, Orla McNally, Nadia Traficante, null Australian Ovarian Cancer Study, Anna De Fazio, David D L Bowtell, Elizabeth M Swisher, S John Weroha, Katia Nones, Nicola Waddell, Scott H Kaufmann, Alexander Dobrovic, Matthew J Wakefield, Clare L Scott
Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. Cancer research 81 (18) (2021)
Yoland Antill, Daniel D Buchanan, Clare L Scott
Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer. Cancer (2021)
Andreas Obermair, Philip Beale, Clare L Scott, Victoria Beshay, Ganessan Kichenadasse, Bryony Simcock, James L Nicklin, Yeh Chen Lee, Paul Andrew Cohen, Tarek M Meniawy
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020. Journal of gynecologic oncology 32 (6) (2021)
Elaine Sanij, Katherine M Hannan, Jiachen Xuan, Shunfei Yan, Jessica E Ahern, Anna Sofia Trigos, Natalie Brajanovski, Jinbae Son, Keefe T Chan, Olga Kondrashova, Elizabeth Lieschke, Matthew J Wakefield, Daniel Frank, Sarah L Ellis, Carleen Cullinane, Jian Kang, Gretchen Poortinga, Purba Nag, Andrew J Deans, Kum Kum Khanna, Linda Mileshkin, Grant A McArthur, John Soong, Els M J J Berns, Ross D Hannan, Clare L Scott, Karen E Sheppard, Richard B Pearson
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer. Nature communications 11 (1) (2020)
Oliver Klein, Damien Kee, Ben Markman, Michael Michael, Craig Underhill, Matteo S Carlino, Louise Jackett, Caroline Lum, Clare L Scott, Adnan Nagrial, Andreas Behren, Jane Y So, Jodie Palmer, Jonathan S Cebon
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Eun Young Kang, Dane Cheasley, Cécile Lepage, Matthew J Wakefield, Michelle da Cunha Torres, Simone Rowley, Carolina Salazar, Zhongyue Xing, Prue Allan, David D L Bowtell, Anne-Marie Mes-Masson, Diane M Provencher, Kurosh Rahimi, Linda E Kelemen, Peter Andreas Fasching, Jennifer A Doherty, Marc T Goodman, Ellen L Goode, Suha Deen, Paul David Peter Pharoah, James D Brenton, Weiva Sieh, Constantina Mateoiu, Karin Sundfeldt, Linda S Cook, Nhu D Le, Michael S Anglesio, C Blake Gilks, David G Huntsman, Catherine J Kennedy, Nadia Traficante, null null, Anna DeFazio, Scott Kaufmann, Michael Churchman, Charlie Gourley, Andrew N Stephens, Nicola S Meagher, Susan J Ramus, Yoland C Antill, Ian G Campbell, Clare L Scott, Martin Koebel, Kylie L Gorringe, null null
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (1) (2020)
Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, Michael S Anglesio, George Au-Yeung, Maret Böhm, David D L Bowtell, Alison Brand, Georgia Chenevix-Trench, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna De Fazio, Renee Demeo, Rhiannon Dudley, Nicole Fairweather, Clare G Fedele, Sian Fereday, Stephen B Fox, C Blake Gilks, Charlie Gourley, Neville F Hacker, Alison M Hadley, Joy Hendley, Gwo-Yaw Ho, Siobhan Hughes, David G Hunstman, Sally M Hunter, Tom W Jobling, Kimberly R Kalli, Scott H Kaufmann, Catherine J Kennedy, Martin Koebel, Cécile Lepage, Jason Li, Richard Lupat, Orla M McNally, Jessica Nell McAlpine, Anne-Marie Mes-Masson, Linda Mileshkin, Diane M Provencher, Jan Pyman, Kurosh Rahimi, Simone M Rowley, Carolina Salazar, Goli Samimi, Hugo Saunders, Timothy Semple, Ragwha Sharma, Alice J Sharpe, Andrew N Stephens, Niko Thio, Michelle C Torres, Nadia Traficante, Zhongyue Xing, Magnus Zethoven, Yoland C Antill, Clare L Scott, Ian G Campbell, Kylie L Gorringe
The molecular origin and taxonomy of mucinous ovarian carcinoma. Nature communications 10 (1) (2019)
Holly E Barker, Clare L Scott
Preclinical rare cancer research to inform clinical trial design. Nature reviews. Cancer 19 (9) (2019)
Olga Kondrashova, Monique Topp, Ksenija Nesic, Elizabeth Lieschke, Gwo-Yaw Ho, Maria I Harrell, Giada V Zapparoli, Alison Hadley, Robert Holian, Emma Boehm, Valerie Heong, Elaine Sanij, Richard B Pearson, John J Krais, Neil Johnson, Orla McNally, Sumitra Ananda, Kathryn Alsop, Karla J Hutt, Scott H Kaufmann, Kevin K Lin, Thomas C Harding, Nadia Traficante, null null, Anna deFazio, Iain A McNeish, David D Bowtell, Elizabeth M Swisher, Alexander Dobrovic, Matthew J Wakefield, Clare L Scott
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. Nature communications 9 (1) (2018)
Quynh-Nhu Nguyen, Nadeen Zerafa, Seng H Liew, F Hamish Morgan, Andreas Strasser, Clare L Scott, Jock K Findlay, Martha Hickey, Karla J Hutt
Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility. Cell death & disease 9 (6) (2018)